Institutional shares held 68.1 Million
52.3K calls
80.3K puts
Total value of holdings $927M
$712K calls
$1.09M puts
Market Cap $689M
49,306,700 Shares Out.
Institutional ownership 138.07%
# of Institutions 148


Latest Institutional Activity in REPL

Top Purchases

Q4 2024
New York State Common Retirement Fund Shares Held: 43.2K ($604K)
Q4 2024
Rhumbline Advisers Shares Held: 95.5K ($1.33M)
Q4 2024
Sg Americas Securities, LLC Shares Held: 26.3K ($368K)
Q4 2024
China Universal Asset Management Co., Ltd. Shares Held: 16.3K ($228K)
Q4 2024
Venturi Wealth Management, LLC Shares Held: 401 ($5.61K)

Top Sells

Q4 2024
Allworth Financial LP Shares Held: 347 ($4.85K)
Q3 2024
Millennium Management LLC Shares Held: 1.15M ($16.1M)
Q3 2024
Redmile Group, LLC Shares Held: 4.78M ($66.8M)
Q3 2024
Schonfeld Strategic Advisors LLC Shares Held: 572K ($8M)
Q3 2024
Jane Street Group, LLC Shares Held: 262K ($3.67M)

About REPL

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.


Insider Transactions at REPL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
177K Shares
From 5 Insiders
Grant, award, or other acquisition 177K shares
Sell / Disposition
195K Shares
From 9 Insiders
Open market or private sale 145K shares
Bona fide gift 50K shares

Track Institutional and Insider Activities on REPL

Follow Replimune Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPL shares.

Notify only if

Insider Trading

Get notified when an Replimune Group, Inc. insider buys or sells REPL shares.

Notify only if

News

Receive news related to Replimune Group, Inc.

Track Activities on REPL